Author

Tianzheng Ye

Cornell UniversityORCID 0000-0001-6678-7115Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:deep learning· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Connor MonticelloiD· 2 shared Matthew P. DeLisaiD· 2 shared Andreas PlückthuniD· 1 shared Azmain AlamgiriD· 1 shared Bunyarit MeksiriporniD· 1 shared Cara M. RobertusiD· 1 shared Christopher A. AlabiiD· 1 shared Darianna Colina· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Connor MonticelloORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringScience AdvancesPeer-reviewedAug 28, 2026

Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations in vitro and in vivo

Tianzheng Ye, Azmain Alamgir, Cara M. Robertus…·Matthew P. DeLisa

This paper develops programmable protein degraders (uAbs) that selectively knock down pathogenic β-catenin in vitro and in vivo, reducing tumor cell survival and proliferation.

5 citationstop 2%

humanmouse

𝕏 PostBluesky

Synthetic BiologyACS Synthetic BiologyPeer-reviewedAug 16, 2021

Engineering single pan-specific ubiquibodies for targeted degradation of all forms of endogenous ERK protein kinase

Erin A. Stephens, Morgan B. Ludwicki, Bunyarit Meksiriporn…·Matthew P. DeLisa

This paper describes the engineering of ubiquibodies (uAbs) that degrade all forms of endogenous ERK1/2 protein kinase in multiple cell lines.

27 citations

humanexperimental assay

𝕏 PostBluesky